Human milk oligosaccharides (HMOs) are complex carbohydrates that are naturally present in human breast milk. They are the third most abundant component in breast milk, after lactose and lipids. HMOs are composed of different kinds of simple sugar molecules, including glucose, galactose, fucose, and sialic acid. Studies suggest that HMOs may protect against infections and reduce inflammation. HMOs have also been found to have anti-adhesive properties that prevent pathogenic bacteria from attaching to the surface of the intestinal wall. Due to their potential health benefits, HMOs are now being added to infant formulas as an alternative to breast milk. Several companies are using HMOs to develop infant formulas that can mimic the beneficial effects of breast milk. The global HMOs market is expected to increase by USD 246.2 million, at a compound annual growth rate (CAGR) of 14.06% from 2023 to 2029, according to the latest edition of the Global Human Milk Oligosaccharides Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global HMOs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for HMOs can be segmented by application: dietary supplements, functional food and beverages, infant formula, others. The infant formula segment held the largest revenue share in 2022. HMOs market is further segmented by region: North America, Europe, Asia-Pacific, Rest of the World (RoW). Among these, Asia-Pacific was accounted for the highest revenue generator in 2022.

Market Segmentation
By application: dietary supplements, functional food and beverages, infant formula, others
By region: North America, Europe, Asia-Pacific, Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global HMOs market. Some of the leading players profiled in the report include BASF SE, Chr. Hansen Holding AS (Jennewein Biotechnologie GmbH), Danisco A/S, Elicityl S.A., Glycosyn LLC, Inbiose NV, International Flavors & Fragrances Inc. (DuPont Nutrition & Biosciences), Koninklijke DSM N.V., Merck & Co. Inc., Royal FrieslandCampina N.V., Shandong Henglu Biotechnology Co., Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global HMOs market.
• To classify and forecast the global HMOs market based on application, region.
• To identify drivers and challenges for the global HMOs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global HMOs market.
• To identify and analyze the profile of leading players operating in the global HMOs market.

Why Choose This Report
• Gain a reliable outlook of the global HMOs market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.